메뉴 건너뛰기




Volumn , Issue 1, 2009, Pages

Hormone replacement therapy to maintain cognitive function in women with dementia

Author keywords

*Hormone replacement therapy; Cognition disorders prevention control ; Cognition *drug effects; physiology ; Dementia *drug therapy ; Estrogen replacement therapy; Female; Humans; Memory drug effects ; Postmenopause blood ; Randomized controlled trials as topic

Indexed keywords

BEIMEILI; CONJUGATED ESTROGEN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; THIAMINE; UNCLASSIFIED DRUG;

EID: 70249121973     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003799.pub2     Document Type: Review
Times cited : (165)

References (51)
  • 1
    • 0033003028 scopus 로고    scopus 로고
    • Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: Results of a placebo- Controlled, double-blind, pilot study
    • DOI 10.1016/S0306-4530(99)00020-7, PII S0306453099000207
    • Asthana S, Craft S, Baker LD, RaskindMA, Birnbaum RS, Lofgreen C, Veith RC, Plymate SR. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with AD: results of a placebo-controlled, double-blind pilot study. Psychoneuroendocrinol- ogy 1999;24:657-677. (Pubitemid 29277256)
    • (1999) Psychoneuroendocrinology , vol.24 , Issue.6 , pp. 657-677
    • Asthana, S.1    Craft, S.2    Baker, L.D.3    Raskind, M.A.4    Birnbaum, R.S.5    Lofgreen, C.P.6    Veith, R.C.7    Plymate, S.R.8
  • 3
    • 0030942683 scopus 로고    scopus 로고
    • The role of estrogen in the treatment of Alzheimer's disease
    • Birge SJ. The role of estrogen in the treatment of Alzheimer's disease. Neurology 1997;48:S36-S41. (Pubitemid 27230091)
    • (1997) Neurology , vol.48 , Issue.5 SUPPL. 7
    • Birge, S.J.1
  • 4
    • 0034711656 scopus 로고    scopus 로고
    • Estrogen for Alzheimer's disease in women
    • Henderson VW, Paganini-Hill A, Miller BL, et al.Estrogen for Alzheimer's disease in women. Neurology 2000;54(2):295-301.
    • (2000) Neurology , vol.54 , Issue.2 , pp. 295-301
    • Henderson, V.W.1    Paganini-Hill, A.2    Miller, B.L.3
  • 6
    • 0000366424 scopus 로고
    • Evaluation of psychologic effects of sex hormone administration in aged women: Results of therapy after 6 months
    • Caldwell BM, Watson RI. Evaluation of psychologic effects of sex hormone administration in aged women: results of therapy after 6 months. Journal of Gerontology 1952;7:228-244
    • (1952) Journal of Gerontology , vol.7 , pp. 228-244
    • Caldwell, B.M.1    Watson, R.I.2
  • 7
    • 0034704547 scopus 로고    scopus 로고
    • Estrogen replacement therapy for treatment ofmild tomoderate Alzheimer's disease
    • Mulnard RA, Cotman CW, Kawas C, et al.Estrogen replacement therapy for treatment ofmild tomoderate Alzheimer's disease. JAMA 2000;283:1007-1015
    • (2000) JAMA , vol.283 , pp. 1007-1015
    • Mulnard, R.A.1    Cotman, C.W.2    Kawas, C.3
  • 10
    • 0022525677 scopus 로고
    • Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type
    • DOI 10.1016/0306-4530(86)90019-3
    • Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986;11:337-345. (Pubitemid 16002256)
    • (1986) Psychoneuroendocrinology , vol.11 , Issue.3 , pp. 337-345
    • Fillit, H.1    Weinreb, H.2    Cholst, I.3
  • 11
    • 0028578027 scopus 로고
    • Estrogens in the Pathogenesis and Treatment of Alzheimer's Disease in PostmenopausalWomen
    • Fillit H. Estrogens in the Pathogenesis and Treatment of Alzheimer's Disease in PostmenopausalWomen. Annals of the New York Academy of Sciences 1994;743:233-239
    • (1994) Annals of the New York Academy of Sciences , vol.743 , pp. 233-239
    • Fillit, H.1
  • 14
    • 0028087659 scopus 로고
    • Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type
    • Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocrine Journal 1994;41:361-371 (Pubitemid 24297493)
    • (1994) Endocrine Journal , vol.41 , Issue.4 , pp. 361-371
    • Ohkura, T.1    Isse, K.2    Akazawa, K.3    Hamamoto, M.4    Yaoi, Y.5    Hagino, N.6
  • 16
    • 0028969073 scopus 로고
    • Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type 7 case reports
    • Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type 7 case reports. Dementia 1995;6:99-107.
    • (1995) Dementia , vol.6 , pp. 99-107
    • Ohkura, T.1    Isse, K.2    Akazawa, K.3    Hamamoto, M.4    Yaoi, Y.5    Hagino, N.6
  • 17
    • 0037435541 scopus 로고    scopus 로고
    • No additional benefit of HRT on response to rivastigmine in menopausal women with AD
    • Rigaud AS, Andre G, Vellas B, Touchon J, Pere MD. No additional benefit of HRT on response to rivastigmine in menopausal women with AD. Neurology 2003;60:148-149 (Pubitemid 36070671)
    • (2003) Neurology , vol.60 , Issue.1 , pp. 148-150
    • Rigaud, A.S.1    Andre, G.2    Vellas, B.3    Touchon, J.4    Pere, J.J.5
  • 18
    • 0037309386 scopus 로고    scopus 로고
    • Hormone replacement therapy in postmenopausal women with Alzheimer's disease: A randomized, prospective study
    • DOI 10.1016/S0015-0282(02)04666-6, PII S0015028202046666
    • Yoon B-K, Kim DH, Kan Y, Kim J-W, Shin M-H, Na DL. Hormone replacement therapy in women with Alzheimer's disease: a randomised prospective study. Fertility and Sterility 2003;79(2):274-280 (Pubitemid 36144049)
    • (2003) Fertility and Sterility , vol.79 , Issue.2 , pp. 274-280
    • Yoon, B.-K.1    Kim, D.K.2    Kang, Y.3    Kim, J.-W.4    Shin, M.-H.5    Na, D.L.6
  • 19
    • 70249145898 scopus 로고    scopus 로고
    • Pulsatile nasal administration of estradiol for postmenopausal complaints
    • Hogervorst E, Henderson V, Gibbs B, Brinton-Diaz R editor(s). Cambridge: Cambridge University Press
    • Al-Azzawi F. Pulsatile nasal administration of estradiol for postmenopausal complaints. In: Hogervorst E, Henderson V, Gibbs B, Brinton-Diaz R editor(s). Hormones, Cognition andDementia. Cambridge: Cambridge University Press, 2008.
    • (2008) Hormones, Cognition AndDementia
    • Al-Azzawi, F.1
  • 20
    • 0004235298 scopus 로고    scopus 로고
    • American Psychiatric Association. Washington, DC: American Psychiatric Association
    • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1999.
    • (1999) Diagnostic and Statistical Manual of Mental Disorders
  • 21
    • 0025944051 scopus 로고
    • Postmenopausal estrogen and prevention bias. Postmenopausal estrogen and prevention bias
    • Barrett-Connor E. Postmenopausal estrogen and prevention bias. Postmenopausal estrogen and prevention bias. Annals of Internal Medicine 1991;115:455-456
    • (1991) Annals of Internal Medicine , vol.115 , pp. 455-456
    • Barrett-Connor, E.1
  • 23
    • 0025651939 scopus 로고
    • Reduced plasma oestrogen stimulated neurophysin and delayed response to oestrogen challenge in AD
    • Christie, et al.Reduced plasma oestrogen stimulated neurophysin and delayed response to oestrogen challenge in AD. Psych Med 1990;20:773-777.
    • (1990) Psych Med , vol.20 , pp. 773-777
    • Christie1
  • 24
    • 0035870838 scopus 로고    scopus 로고
    • Hormone replacement therapy after breast cancer: A systematic review and quantitative assessment of risk
    • Col NF, Hirota LK, Orr RK, Erban JK, Wong JB, Lau J. Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk. Journal of Clinical Oncology 2001;19 (8):2357-2363 (Pubitemid 32372327)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.8 , pp. 2357-2363
    • Col, N.F.1    Hirota, L.K.2    Orr, R.K.3    Erban, J.K.4    Wong, J.B.5    Lau, J.6
  • 25
    • 18244428862 scopus 로고    scopus 로고
    • Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group
    • Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al.Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(11):S10-15.
    • (2000) Neurology , vol.54 , Issue.11
    • Fratiglioni, L.1    Launer, L.J.2    Andersen, K.3    Breteler, M.M.4    Copeland, J.R.5    Dartigues, J.F.6
  • 26
    • 70249132641 scopus 로고    scopus 로고
    • Animal studies that support estrogen effects on cognitive performance and the cholinergic basis of the critical period hypothesis
    • Hogervorst E,Henderson V, Gibbs B, Brinton-Diaz R editor (s). Cambridge: Cambridge University Press
    • Gibbs RB. Animal studies that support estrogen effects on cognitive performance and the cholinergic basis of the critical period hypothesis. In: Hogervorst E,Henderson V, Gibbs B, Brinton-Diaz R editor (s). Hormones, Cognition and Dementia. Cambridge: Cambridge University Press, 2008.
    • (2008) Hormones, Cognition and Dementia
    • Gibbs, R.B.1
  • 27
    • 70249117202 scopus 로고    scopus 로고
    • The critical window hypothesis: Hormone exposure and cognitive outcomes after menopause
    • Hogervorst E, Henderson V, Gibbs B, Brinton-Diaz R editor(s). Cambridge: Cambridge University Press
    • Henderson VH. The critical window hypothesis: hormone exposure and cognitive outcomes after menopause. In: Hogervorst E, Henderson V, Gibbs B, Brinton-Diaz R editor(s). Hormones, Cognition and Dementia. Cambridge: Cambridge University Press, 2008.
    • (2008) Hormones, Cognition and Dementia
    • Henderson, V.H.1
  • 28
    • 0034669062 scopus 로고    scopus 로고
    • The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: A meta-analysis
    • DOI 10.1016/S0306-4522(00)00410-3, PII S0306452200004103
    • Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000;101(3):485-512. (Pubitemid 30953107)
    • (2000) Neuroscience , vol.101 , Issue.3 , pp. 485-512
    • Hogervorst, E.1    Williams, J.2    Budge, M.3    Riedel, W.4    Jolles, J.5
  • 29
    • 34948833099 scopus 로고    scopus 로고
    • Should surgical menopausal women be treated with estrogens to decrease the risk of dementia?
    • DOI 10.1212/01.wnl.0000279584.03800.3d, PII 0000611420070911000002
    • Hogervorst E, Bandelow S. Should surgically menopausal women be treated with estrogens to decrease the risk for dementia?. Neurology, Invited Editorial 2007;69(11):1070-1071 (Pubitemid 47517550)
    • (2007) Neurology , vol.69 , Issue.11 , pp. 1070-1071
    • Hogervorst, E.1    Bandelow, S.2
  • 30
    • 0031475117 scopus 로고    scopus 로고
    • Ageing, cognition and dementia
    • Dec 26
    • Huppert F, Wilcock G. Ageing, cognition and dementia. Age and Ageing 1997;Dec 26(Suppl 4):20-23
    • (1997) Age and Ageing , Issue.SUPPL. 4 , pp. 20-23
    • Huppert, F.1    Wilcock, G.2
  • 31
    • 0032901080 scopus 로고    scopus 로고
    • Rates and risk factors for dementia and Alzheimer's disease
    • Launer LJ, Andersen K, Dewy ME, et al.Rates and risk factors for dementia and Alzheimer's disease. Neurology 1999;1:78-84.
    • (1999) Neurology , vol.1 , pp. 78-84
    • Launer, L.J.1    Andersen, K.2    Dewy, M.E.3
  • 32
    • 0035925762 scopus 로고    scopus 로고
    • Hormone replacement therapy and cognition
    • LeBlanc ES, Janowsky J, Chan BKS, Nelson HD.Hormone replacement therapy and cognition. JAMA 2001;285(11):1489-1499
    • (2001) JAMA , vol.285 , Issue.11 , pp. 1489-1499
    • LeBlanc, E.S.1    Janowsky, J.2    Chan, B.K.S.3    Nelson, H.D.4
  • 33
    • 44949199302 scopus 로고    scopus 로고
    • Hormone replacement therapy for cognitive function in postmenopausal women
    • DOI 10.1002/14651858.CD003122.pub2
    • Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD003122. pub2] (Pubitemid 351807570)
    • (2008) Cochrane Database of Systematic Reviews , Issue.1
    • Lethaby, A.1    Hogervorst, E.2    Richards, M.3    Yesufu, A.4    Yaffe, K.5
  • 35
    • 0030968187 scopus 로고    scopus 로고
    • Ovarian steroids and the brain: Implications for cognition and aging
    • McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain implications for cognition and aging. Neurology 1997;48:S14-S18. (Pubitemid 27230087)
    • (1997) Neurology , vol.48 , Issue.5 SUPPL. 7
    • McEwen, B.S.1    Alves, S.E.2    Bulloch, K.3    Weiland, N.G.4
  • 36
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
    • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;4:939-944 (Pubitemid 14076461)
    • (1984) Neurology , vol.34 , Issue.7 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 38
    • 0035972811 scopus 로고    scopus 로고
    • Hormone replacement therapy and stroke: Risk, protection or no effect? Hormone replacement therapy and stroke: risk, protection or no effect?
    • Paganini-Hill A. Hormone replacement therapy and stroke: risk, protection or no effect? Hormone replacement therapy and stroke: risk, protection or no effect?. Maturitas 2001;38(3):243-261
    • (2001) Maturitas , vol.38 , Issue.3 , pp. 243-261
    • Paganini-Hill, A.1
  • 40
    • 85047692188 scopus 로고
    • Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
    • Schulz KF,Chalmers I,Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
    • (1995) JAMA , vol.273 , pp. 408-412
    • Schulz, K.F.1    Chalmers, I.2    Hayes, R.J.3    Altman, D.G.4
  • 41
    • 0032430616 scopus 로고    scopus 로고
    • The WHIMS: A trial of estrogen therapy in preventing and slowing the progression of dementia
    • Schumaker, et al.The WHIMS: a trial of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998;19:604-621.
    • (1998) Control Clin Trials , vol.19 , pp. 604-621
    • Schumaker1
  • 44
    • 0035961223 scopus 로고    scopus 로고
    • Estrogen and the aging brain
    • Silva I, Mor G, Naftolin F. Estrogen and the aging brain. Maturitas 2001;38(1):100-101
    • (2001) Maturitas , vol.38 , Issue.1 , pp. 100-101
    • Silva, I.1    Mor, G.2    Naftolin, F.3
  • 45
    • 0034686614 scopus 로고    scopus 로고
    • Estrogen as a treatment for AD: Commentary
    • Toran-Allerand CD. Estrogen as a treatment for AD: commentary. JAMA 2000;284:307-308
    • (2000) JAMA , vol.284 , pp. 307-308
    • Toran-Allerand, C.D.1
  • 46
    • 33745125400 scopus 로고    scopus 로고
    • Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination
    • WegienkaG,Havstad S, Kelsey JL.Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination. Journal of Women's Health 2006; 15(4):369-378
    • (2006) Journal of Women's Health , vol.15 , Issue.4 , pp. 369-378
    • Wegienka, G.1    Havstad, S.2    Kelsey, J.L.3
  • 48
    • 0031818145 scopus 로고    scopus 로고
    • Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women
    • Yaffe K, Grady D, Pressman A, Cummings S. Serum estrogen levels, cognitive performance and risk of cognitive decline in older community women. Journal of the American Geriatrics Sociaty 1998;46: 816-821 (Pubitemid 28328494)
    • (1998) Journal of the American Geriatrics Society , vol.46 , Issue.7 , pp. 816-821
    • Yaffe, K.1    Grady, D.2    Pressman, A.3    Cummings, S.4
  • 49
    • 0034718373 scopus 로고    scopus 로고
    • Cognitive decline in women in relation to non-protein-bound oestradiol concentrations
    • Yaffe K, et al.Cognitive decline in women with relation to non-protein bound estradiol concentrations. Lancet 2000;356:708-712 (Pubitemid 30663239)
    • (2000) Lancet , vol.356 , Issue.9231 , pp. 708-712
    • Yaffe, K.1    Lui, L.-Y.2    Grady, D.3    Cauley, J.4    Kramer, J.5    Cummings, S.R.6
  • 50
    • 33947611967 scopus 로고    scopus 로고
    • Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women
    • DOI 10.2217/17455057.3.2.173
    • Yesufu A, Bandelow S, Hogervorst E. Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women. Women's Health invited review 2007;3(2):173-195 (Pubitemid 46488180)
    • (2007) Women's Health , vol.3 , Issue.2 , pp. 173-194
    • Yesufu, A.1    Bandelow, S.2    Hogervorst, E.3
  • 51
    • 70249121973 scopus 로고    scopus 로고
    • Hormone replacement therapy to maintain cognitive function in women with dementia
    • [DOI: 10.1002/14651858.CD003799] Indicates the major publication for the study
    • Hogervorst E, Yaffe K, Richards M, Huppert F. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003799] * Indicates the major publication for the study
    • (2002) Cochrane Database of Systematic Reviews , Issue.3
    • Hogervorst, E.1    Yaffe, K.2    Richards, M.3    Huppert, F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.